JOHNSON & JOHNSON
JOHNSON & JOHNSON
Share · US4781601046 · JNJ · 853260 (XNYS)
Overview
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
19
17
3
0
No Price
29.01.2026 00:55
Current Prices from JOHNSON & JOHNSON
ExchangeTickerCurrencyLast TradePriceDaily Change
XNYS: NYSE
NYSE
JNJ
USD
29.01.2026 00:55
228,19 USD
0,47 USD
+0,21 %
XETR: XETRA
XETRA
JNJ.DE
EUR
28.01.2026 16:03
190,42 EUR
2,76 EUR
+1,47 %
XFRA: Frankfurt
Frankfurt
JNJ.F
EUR
28.01.2026 14:47
190,36 EUR
2,94 EUR
+1,57 %
XDQU: Quotrix
Quotrix
JJRSDL46.DUSD
EUR
28.01.2026 12:16
188,02 EUR
0,60 EUR
+0,32 %
XHAN: Hannover
Hannover
JJRSDL46.HANB
EUR
28.01.2026 07:01
188,02 EUR
0,60 EUR
+0,32 %
XHAM: Hamburg
Hamburg
JJRSDL46.HAMB
EUR
28.01.2026 07:01
188,02 EUR
0,60 EUR
+0,32 %
XDUS: Düsseldorf
Düsseldorf
JJRSDL46.DUSB
EUR
27.01.2026 18:31
187,62 EUR
1,48 EUR
+0,80 %
ESG Risk Rating
B+ Good
Share Float & Liquidity
Free Float 99,88 %
Shares Float 2,41 B
Shares Outstanding 2,41 B
Invested Funds

The following funds have invested in JOHNSON & JOHNSON:

Fund
iShares MSCI USA Islamic UCITS ETF USD (Dist)
Vol. in million
11.885,14
Percentage (%)
7,11 %
Fund
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in million
21.456,84
Percentage (%)
5,88 %
Fund
iShares MSCI World Quality Dividend UCITS ETF USD (Acc)
Vol. in million
1.867,23
Percentage (%)
3,92 %
Fund
iShares MSCI World Islamic UCITS ETF USD (Dist)
Vol. in million
12.780,82
Percentage (%)
3,89 %
Fund
iShares Dow Jones Industrial Average UCITS ETF (DE)
Vol. in million
8.737,62
Percentage (%)
3,24 %
Company Profile for JOHNSON & JOHNSON Share
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
AI Analysis of JOHNSON & JOHNSON
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of JOHNSON & JOHNSON
No AI threads available for this company yet.

Company Data

Name JOHNSON & JOHNSON
Company Johnson & Johnson
Symbol JNJ
Website https://www.jnj.com
Primary Exchange XNYS NYSE
WKN 853260
ISIN US4781601046
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Joaquin Duato
Market Capitalization 461 Mrd.
Country United States of America
Currency USD
Employees 138,1 T
Address One Johnson & Johnson Plaza, 08933 New Brunswick
IPO Date 2007-12-28
Dividends from 'JOHNSON & JOHNSON'
Ex-Date Dividend per Share
25.11.2025 1,30 USD
26.08.2025 1,30 USD
27.05.2025 1,30 USD
18.02.2025 1,24 USD
26.11.2024 1,24 USD
27.08.2024 1,24 USD
20.05.2024 1,24 USD
16.02.2024 1,19 USD
20.11.2023 1,19 USD
25.08.2023 1,19 USD

Stock Splits

Date Split
13.06.2001 2:1
12.06.1996 2:1
10.06.1992 2:1
11.05.1989 2:1
19.05.1981 3:1
18.05.1970 3:1
19.06.1967 3:1

Ticker Symbols

Name Symbol
Düsseldorf JJRSDL46.DUSB
Frankfurt JNJ.F
Hamburg JJRSDL46.HAMB
Hannover JJRSDL46.HANB
NYSE JNJ
Quotrix JJRSDL46.DUSD
XETRA JNJ.DE
More Shares
Investors who hold JOHNSON & JOHNSON also have the following shares in their portfolio:
ALLIANZ AG
ALLIANZ AG Share
AMAZON.CO INC
AMAZON.CO INC Share
APPLE INC
APPLE INC Share
COCA-COLA CO
COCA-COLA CO Share
EUWAX GOLD
EUWAX GOLD ETC
GREENRISE GLOBAL BRANDS
GREENRISE GLOBAL BRANDS Share
Labo Print S.A.
Labo Print S.A. Share
MCDONALDS CORP
MCDONALDS CORP Share
META PLATFORMS INC
META PLATFORMS INC Share
MICROSOFT CORP
MICROSOFT CORP Share
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Share
ROCKFIRE RESOUR. LS -,001
ROCKFIRE RESOUR. LS -,001 Share
TESLA INC
TESLA INC Share
UNILEVER PLC
UNILEVER PLC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026